Cytokines in influenza in children (literature review)

QR Code

Cytokines in influenza in children (literature review)

This literature review was compiled according to the data of search engines PubMed, eLIBRARY.RU, Google Scholar using key words influenza, cytokines, children. The article highlights the participation of pro-inflammatory and antiinflammatory cytokines in the pathogenesis of influenza, compares the c...

Full description

Saved in:

Bibliographic Details
Main Authors:	E. D. Kazantseva, A. G. Petrova, L. V. Rychkova, M. A. Darenskaya
Format:	Article
Language:	Russian
Published:	Russian Academy of Sciences, Siberian Branch Publishing House 2024-03-01
Series:	Сибирский научный медицинский журнал
Subjects:	influenza a/(h1n1)pdm09 influenza a (h3n2) influenza b cytokines children
Online Access:	https://sibmed.elpub.ru/jour/article/view/1396
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparative characteristics of clinical, laboratory and instrumental indicators in children with seasonal influenza depending on the virus strain
by: E. D. Kazantseva, et al.
Published: (2022-12-01)

Differences Depending on the Etiology of Influenza Epidemics in 2014-2017
by: L. S. Karpova, et al.
Published: (2018-02-01)

Integrated In Silico, In Vitro, and In Vivo Studies Reveal Mangiferin as a Promising Antiviral Agent Against H1N1/pdm2009 Influenza Virus
by: Yinde Gan, et al.
Published: (2025-06-01)

Catamnesis of children from mothers who had A(H1N1)pdm09 influenza during pregnancy
by: D. A. Tarbaeva, et al.
Published: (2016-04-01)

Genetic characterization of influenza A viruses circulating in Hong Kong, China, 2023: the first influenza epidemic after the lifting of 2.5 years of COVID-19 non-pharmaceutical interventions
by: Jingyuan Bian, et al.
Published: (2025-12-01)

Clinical course of respiratory mixed infection caused by five pathogens - <i>SARS-CoV-2</i>, influenza A(<i>H<sub>1</sub>N<sub>1</sub></i>)pdm09, <i>Streptococcus pneumoniae</i>, <i>Mycoplasma pneumonia</i>, <i>Candida albicans</i> in a young patient
by: X. A. Dmitrenko, et al.
Published: (2024-04-01)

Organizing Medical Care to Patients with Severe Pneumonias in the Presence of A/H1N1 Influenza
by: K. G. Shapovalov, et al.
Published: (2010-04-01)

Epidemiological Features of Pandemic Influenza in Kyrgyzstan due to Influenza A(H1N1)pdm
by: K. T. Kasymbekova, et al.
Published: (2016-10-01)

ОСОБЕННОСТИ ГРИППОЗНЫХ ПНЕВМОНИЙ У ПАЦИЕНТОВ ПУЛЬМОНОЛОГИЧЕСКОГО СТАЦИОНАРА В ПЕРИОД ЭПИДЕМИИ ГРИППА А(H1N1) PDM09
by: Ф. Т. Малыхин, et al.
Published: (2012-04-01)

Influence of the ways of spreading influenza epidemics across the territory Russia on the peculiarities of the epidemic process in various Federal districts
by: L. S. Karpova, et al.
Published: (2021-12-01)

Features of Isotypic Structure of Virus-Specific Systemic Humoral Immune Response in Adult Volunteers Immunized with Inactivated Monovalent Subunit Vaccines against Pandemic Influenza A(H1N1)pdm09
by: A. A. Vasileva, et al.
Published: (2016-04-01)

In vitro Efficacy of Ingavirin® against the Pandemic Influenza Virus A(H1N1/09)v
by: L. N. Shishkina, et al.
Published: (2020-05-01)

IN VITRO INTERACTION OF INFLUENZA VIRUS A(H1N1)pdm09 WITH MONOCYTIC MACROPHAGES: INDIVIDUAL RESPONSES OF TLR7 AND RIG1 RECEPTOR GENES
by: T. M. Sokolova, et al.
Published: (2017-12-01)

Real-world effectiveness of live attenuated influenza vaccines (LAIV) and inactivated influenza vaccines (IIV) in children from 2003 to 2023: a systematic literature review and network meta-analysis
by: Anke L. Stuurman, et al.
Published: (2025-12-01)

In vivo Efficacy of Ingavirin® Against Pandemic A(H1N1/09)v Influenza Virus
by: L. N. Shishkina, et al.
Published: (2020-05-01)

CYTOKINE LEVELS IN BLOOD (IFNγ, TNFα, IL-10) AND INTERCELLULAR ADHESION MOLECULE (sICAM-1) IN PATIENTS WITH PNEUMONIA INFLUENZA A/H1N1
by: E. N. Romanova, et al.
Published: (2014-07-01)

Two pandemics of the 21st century: COVID-19 and «swine flu» of 2009
by: T. N. Ilyicheva
Published: (2021-01-01)

Experience of Organizational-Preventive Measures in Rostov Region in the Influenza Epidemic Season of 2015 - 2016
by: E. V. Kovalev, et al.
Published: (2017-04-01)

Protective Activity of Ingavirin® in Experimental Lethal Influenza Due to Pandemic Influenza Virus A (H1N1)v (Albino Mice)
by: V. V. Zarubaev, et al.
Published: (2020-05-01)

GENETIC PREDICTORS OF SEVERE COMPLICATED INFLUENZA A(H1 N1) IN PREGNANT WOMEN
by: D. A. Tarbaeva, et al.
Published: (2015-09-01)

Investigation of Ingavirin® Antiviral Activity Against Season Influenza Virus A/H1N1 in MDCK Cell Culture
by: G. A. Galegov, et al.
Published: (2020-05-01)

Clinical features of a fatal case of acute encephalitis associated with a novel influenza H3N2 recombinant virus possessing human-origin H7N9 internal genes: a descriptive study
by: Wenlei Wang, et al.
Published: (2025-12-01)

Study of Ingavirin® Antiviral Activity against Mexican Pandemic Influenza Virus A/H1N1/2009 in vitro and in vivo
by: S. YA. Loginova, et al.
Published: (2020-05-01)

In vitro Efficacy of Ingavirin Against the Mexican Pandemic Subtype H1N1 of Influenza A Virus, Strains A/California/04/2009 and A/California/07/2009
by: S. YA. Loginova, et al.
Published: (2020-05-01)

Features of Epidemic Process of Influenza and its Etiology in the Countries of the Northern and Southern Hemispheres in the Period of Circulation of Pandemic Virus A(H1N1)pdm09 (According to WHO)
by: L. S. Karpova, et al.
Published: (2020-01-01)

Waning intra-season vaccine effectiveness against influenza A(H3N2) underlines the need for more durable protection
by: Alexander Domnich, et al.
Published: (2024-12-01)

Results of Epidemiological Monitoring Bird Flu in Kyrgyz Republic
by: K. T. Kasymbekova, et al.
Published: (2016-12-01)

Neutralization of the Pandemic Influenza A/H1N1 Virus with <i>Lama glama</i> Humanized Nanobodies (VHH)
by: Zeila Yazmín Páez-Hernández, et al.
Published: (2025-05-01)

Acute kidney injury in patients with pneumonia with A/H1N1 influenza
by: A. V. Malyarchikov, et al.
Published: (2021-08-01)

Inflammatory markers and organ dysfunction in patients with severe influenza A (H1N1) virus-associated pneumonia
by: А. V. Malyarchikov, et al.
Published: (2022-03-01)

Genetic Characterization of Highly Pathogenic Avian Influenza A(H5N1) Clade 2.3.4.4b, Antarctica, 2024
by: Victor Neira, et al.
Published: (2025-08-01)

BLOOD CONTENTS OF DEFENSINS IN PATIENTS WITH PNEUMONIAS CAUSED BY INFLUENZA А/H1N1
by: E. N. Romanova, et al.
Published: (2014-07-01)

Role of proteins MRP8 (S100A8) and MRP14 (S100A9) in the development of critical condition in patients with pneumonia with A/H1N1 influenza
by: A. V. Malyarchikov, et al.
Published: (2021-08-01)

The role of Toll-like receptor 4 gene polymorphism in the development of organ dysfunction in patients with severe pneumonia associated with A/H1N1 influenza
by: A. V. Malyarchikov, et al.
Published: (2023-03-01)

Therapeutic Efficacy of Triazavirin, a Novel Russian Chemotherapeutic, Against Influenza Virus A (H5N1)
by: S. A. Loginova, et al.
Published: (2020-05-01)

Isolation of Highly Pathogenic Avian Influenza A(H5N1) Virus from Cat Urine after Raw Milk Ingestion, United States
by: Elisha A. Frye, et al.
Published: (2025-08-01)

Susceptibility and shedding in Mx1+ and Mx1− female mice experimentally infected with dairy cattle A(H5N1) influenza virusesResearch in context
by: Asim Biswas, et al.
Published: (2025-08-01)

STUDY OF PATHOGENETIC FEATURES INFECTIOUS CAUSED BY HIGHLY PATHOGENIC INFLUENZA VIRUS A/H5N1 IN WILD DUCKS AND DOMESTIC CHICKEN
by: E. R. Abdullazyanova, et al.
Published: (2012-09-01)

Transmission Dynamics of Highly Pathogenic Avian Influenza A(H5N1) and A(H5N6) Viruses in Wild Birds, South Korea, 2023–2024
by: Ye-Ram Seo, et al.
Published: (2025-08-01)

Febrile neutropenia due to H1N1 infection: Rare entity
by: Ayberk A. Besen, et al.
Published: (2016-01-01)